Posts Tagged ‘Biotech’
Swiss Biotech HemostOD Secures CHF 2 Million Innosuisse Grant to Advance Universal Platelet Technology
Swiss Health Valley biotech company HemostOD has been awarded a CHF 2 million competitive grant from Innosuisse, the Swiss Innovation Agency, to support key development milestones for its groundbreaking platelet manufacturing platform. The non-dilutive funding will play a pivotal role in strengthening HemostOD’s financial position as it moves towards major value-inflection points, including progressing toward…
Read MoreGivaudan Invests USD 110 Million in New Fragrance Facility in Mexico
Givaudan has announced a strategic investment of USD 110 million to build a new fragrance compounding facility in Pedro Escobedo, Mexico, reinforcing its presence in Latin America and supporting its long-term growth ambitions under the company’s 2030 strategy. The new site will operate under Givaudan’s “in the region, for the region” supply model, bringing production…
Read MorePfizer Prize: HUG, UNIL and UNIFR Researchers Awarded
Three Swiss Health Valley research projects have been awarded the Prix Pfizer de la recherche biomédicale 2026, showcasing innovation across cancer immunotherapy, digital health, and personalized medicine. Each project received a CHF 20,000 grant. Personalized cancer vaccine – HUGA research team led by Nicolas Mach, together with Rémi Vernet and Eugenio Fernandez at the HUG…
Read MoreMPC Therapeutics launches MitoStem™ to boost CAR-T Cell Durability
The Geneva-based biotech company announces the commercial launch of MitoStem™, a novel T-cell quality enhancer designed to improve the durability and effectiveness of CAR-T therapies through mitochondrial metabolic reprogramming. MitoStem™ increases the proportion of stem cell memory T cells (Tscm), a key immune cell subtype strongly linked to long-lasting therapeutic responses. By reprogramming cellular metabolism,…
Read More4 New FIT Tech Grants To Life Sciences Projects
Four projects have received support from the Foundation for Innovation and Technology (FIT) in the form of CHF 100’000 Tech Grants: PreciMune and Tamaro Bioscience from CHUV, and Germion Therapeutics and Obstetrical Care Solutions from EPFL will be able to continue developing their technologies with the backing of the Foundation. PreciMune delivers superior immune profiling…
Read MoreAltiscreen receives CHF 150,000 from Venture Kick
The Jura-based medtech startup Altiscreen has obtained CHF 150,000 from Venture Kick to build a portable drug-testing solution that delivers clear results in just three minutes. Its device is designed to support roadside checks, workplace screening, and mobile healthcare teams that need reliable information on the spot. Every day, delayed or unreliable field drug tests…
Read MoreDatabaum and Lemna Bio Receive a Tech Seed Loan from FIT
Two Tech Seed loans of CHF 100,000 each were awarded by FIT to Databaum , an artificial intelligence platform for farmers that transforms raw data from the field into intelligent decisions; and to Lemna Bio, where artificial intelligence is used to understand biological interactions. databaum: data intelligence for regenerative agriculture Agriculture can only be truly…
Read MoreTestmate Health Partners with Intermountain Health
Testmate Health and Intermountain Health have announced a strategic partnership and investment to accelerate access to rapid, low-cost molecular tests for sexually transmitted infections (STIs) in the U.S. This collaboration positions Intermountain Health and Testmate Health to bring lab-quality STI diagnostics to at-risk communities. STIs remain a largely silent epidemic, with 80% of chlamydia and…
Read MorePacrim Group Acquires Majority Stake in Medropharm AG
Valais-based Pacrim Group has taken a major strategic step in the Swiss life-science landscape by acquiring a controlling majority of Medropharm AG, a pioneer in pharmaceutical-grade cannabis.
Read MoreTakeda Unveils New State-of-the-Art Biotech Facility in Neuchâtel
Japonese company Takeda has reached an important milestone in Western Switzerland with the inauguration of a new aseptic filling facility in Neuchâtel — a major investment that strengthens both regional innovation and global access to life-changing therapies. With more than CHF 200 Million invested, this is the largest expansion ever made at the site. Boosting…
Read More